Oramed Pharmaceuticals (Oramed Pharmaceuticals) Pre-Tax Income : $5.09 Mil (TTM As of Dec. 2023)

Oramed Pharmaceuticals Pre-Tax Income Chart

Oramed Pharmaceuticals Annual Data
	Trend	Aug14	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Dec22	Dec23
Pre-Tax Income		Get a 7-Day Free Trial					-14.06	-11.51	-22.99	-37.66	5.09

Oramed Pharmaceuticals Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															-8.74	-3.61	-1.31	-3.28	13.30

Competitive Comparison of Oramed Pharmaceuticals's Pre-Tax Income

For the Biotechnology subindustry, Oramed Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oramed Pharmaceuticals's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oramed Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Oramed Pharmaceuticals's Pre-Tax Income falls into.

Oramed Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Oramed Pharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Oramed Pharmaceuticals's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oramed Pharmaceuticals  (NAS:ORMP) Pre-Tax Income Explanation

Oramed Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

During the past 13 years, Oramed Pharmaceuticals's highest Pretax Margin was 379.70%. The lowest was -1502.18%. And the median was -519.83%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oramed Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Oramed Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Oramed Pharmaceuticals (Oramed Pharmaceuticals) Business Description